Literature DB >> 12709379

Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia.

M Rebecca Fokkema1, Marleen F Gilissen, Jasper J Van Doormaal, Marcel Volmer, Ido P Kema, Frits A J Muskiet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12709379     DOI： 10.1373/49.5.818

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  5 in total

1.  Sex-specific association of sequence variants in CBS and MTRR with risk for promoter hypermethylation in the lung epithelium of smokers.

Authors:  Kristina G Flores; Christine A Stidley; Amanda J Mackey; Maria A Picchi; Sally P Stabler; Jill M Siegfried; Tim Byers; Marianne Berwick; Steven A Belinsky; Shuguang Leng
Journal:  Carcinogenesis       Date:  2012-06-04       Impact factor: 4.944

Review 2.  Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview.

Authors:  R Castro; I Rivera; H J Blom; C Jakobs; I Tavares de Almeida
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

3.  The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.

Authors:  Wiliam Davis; Susan J van Rensburg; Frans J Cronje; Lindiwe Whati; Leslie R Fisher; Lize van der Merwe; Dieter Geiger; M Shafick Hassan; Tandi Matsha; Rajiv T Erasmus; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2014-02-18       Impact factor: 3.584

4.  Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of Women.

Authors:  Aaron W Aday; Edward K Duran; Martin Van Denburgh; Eunjung Kim; William G Christen; JoAnn E Manson; Paul M Ridker; Aruna D Pradhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-05-27       Impact factor: 10.514

5.  Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Jiaqi Huang; Alison M Mondul; Stephanie J Weinstein; Stella Koutros; Andriy Derkach; Edward Karoly; Joshua N Sampson; Steven C Moore; Sonja I Berndt; Demetrius Albanes
Journal:  Br J Cancer       Date:  2016-09-27       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.